93 related articles for article (PubMed ID: 2887146)
1. [Value of beta blockers in the treatment of recurrent ventricular tachycardia in cardiac insufficiency].
Hermida JS; Coumel P; Leclercq JF; Cauchemez B; Maison-Blanche P; Leenhardt A; Slama R
Arch Mal Coeur Vaiss; 1987 Mar; 80(3):290-300. PubMed ID: 2887146
[TBL] [Abstract][Full Text] [Related]
2. [Combination of celiprolol and amiodarone in the treatment of recurrent ventricular tachycardia].
Tonet J; Hidden F; Naditch L; Coutte R; Himbert C; Frank R
Ann Cardiol Angeiol (Paris); 1996 Jan; 45(1):18-23. PubMed ID: 8815771
[TBL] [Abstract][Full Text] [Related]
3. Nonsustained ventricular tachycardia as a predictor for sudden death in patients with idiopathic dilated cardiomyopathy. The role of amiodarone treatment.
Castelli G; Ciaccheri M; Cecchi F; Troiani V; Nannini M; Marconi P; Olivotto J; Montereggi A; Dolara A
G Ital Cardiol; 1999 May; 29(5):514-23. PubMed ID: 10367218
[TBL] [Abstract][Full Text] [Related]
4. [Safety and tolerability of beta-blockers in severe cardiac decompensation from dilated cardiomyopathy].
Sinagra G; Perkan A; Zecchin M; Di Lenarda A; Lardieri G; Rakar S; Secoli G; Pinamonti B; Camerini F
G Ital Cardiol; 1995 Oct; 25(10):1255-63. PubMed ID: 8682221
[TBL] [Abstract][Full Text] [Related]
5. [Prognostic factors after sustained ventricular fibrillation or tachycardia. A multivariate study apropos of 160 cases].
Fleurant E; Lacroix D; Klug D; Warembourg H; Kacet S; Lekieffre J
Arch Mal Coeur Vaiss; 1996 Apr; 89(4):435-44. PubMed ID: 8763003
[TBL] [Abstract][Full Text] [Related]
6. [The use of beta blockers in heart failure: clinical studies].
Cobelli F
Ital Heart J Suppl; 2000 Aug; 1(8):996-1002. PubMed ID: 10993005
[TBL] [Abstract][Full Text] [Related]
7. Noninvasive arrhythmia risk stratification in idiopathic dilated cardiomyopathy: results of the Marburg Cardiomyopathy Study.
Grimm W; Christ M; Bach J; Müller HH; Maisch B
Circulation; 2003 Dec; 108(23):2883-91. PubMed ID: 14623812
[TBL] [Abstract][Full Text] [Related]
8. [Efficacy of the combination of low doses of beta-blockers and amiodarone in the treatment of refractory ventricular tachycardia].
Tonet J; Frank R; Fontaine G; Grosgogeat Y
Arch Mal Coeur Vaiss; 1989 Sep; 82(9):1511-7. PubMed ID: 2573326
[TBL] [Abstract][Full Text] [Related]
9. [Arrhythmia and anti-arrhythmia therapy as prognostic risks].
Meinertz T; Zehender M; Hofmann T; Hohnloser S; Just H
Herz; 1991 Sep; 16 Spec No 1():314-7, 323. PubMed ID: 1820298
[TBL] [Abstract][Full Text] [Related]
10. [Evaluation of ventricular tachycardia by endocavitary stimulation. Apropos of 46 cases].
Cassagneau B; Calazel J; Puel J; Fauvel JM; Bounhoure JP; Marin T; Narula OS
Arch Mal Coeur Vaiss; 1984 Jun; 77(6):652-60. PubMed ID: 6431929
[TBL] [Abstract][Full Text] [Related]
11. Catheter ablation and antiarrhythmic drugs for haemodynamically tolerated post-infarction ventricular tachycardia; long-term outcome in relation to acute electrophysiological findings.
Della Bella P; De Ponti R; Uriarte JA; Tondo C; Klersy C; Carbucicchio C; Storti C; Riva S; Longobardi M
Eur Heart J; 2002 Mar; 23(5):414-24. PubMed ID: 11846499
[TBL] [Abstract][Full Text] [Related]
12. Heart failure and sudden death in patients with tachycardia-induced cardiomyopathy and recurrent tachycardia.
Nerheim P; Birger-Botkin S; Piracha L; Olshansky B
Circulation; 2004 Jul; 110(3):247-52. PubMed ID: 15226218
[TBL] [Abstract][Full Text] [Related]
13. [Prognosis of ventricular tachycardia].
Djiane P; Tafani C; Bonnet JL; Villain P; Habib G; Bory M; Serradimigni A
Arch Mal Coeur Vaiss; 1988 Oct; 81(10):1167-72. PubMed ID: 3146954
[TBL] [Abstract][Full Text] [Related]
14. Pharmacologic treatment of dilated cardiomyopathy with special reference to the role of beta-blockers.
Waagstein F
Herz; 1985 Jun; 10(3):143-8. PubMed ID: 2862098
[TBL] [Abstract][Full Text] [Related]
15. The role of implantable cardioverter defibrillator for primary vs secondary prevention of sudden death in patients with idiopathic dilated cardiomyopathy.
Zecchin M; Di Lenarda A; Proclemer A; Faganello G; Facchin D; Petz E; Sinagra G
Europace; 2004 Sep; 6(5):400-6. PubMed ID: 15294264
[TBL] [Abstract][Full Text] [Related]
16. Long-term follow-up and risk assessment of arrhythmogenic right ventricular dysplasia/cardiomyopathy: personal experience from different primary and tertiary centres.
Peters S
J Cardiovasc Med (Hagerstown); 2007 Jul; 8(7):521-6. PubMed ID: 17568286
[TBL] [Abstract][Full Text] [Related]
17. [Sustained ventricular tachycardia: induced polymorphism. Clinical and electrophysiological aspects; therapeutic implications].
Vergara G; Disertori M; Inama G; Guarnerio M; Bettini R; Durante G; Stirpe E; Furlanello F
G Ital Cardiol; 1984 Dec; 14(12):972-81. PubMed ID: 6532893
[TBL] [Abstract][Full Text] [Related]
18. Role of nonsustained ventricular tachycardia and programmed ventricular stimulation for risk stratification in patients with idiopathic dilated cardiomyopathy.
Becker R; Haass M; Ick D; Krueger C; Bauer A; Senges-Becker JC; Voss F; Hilbel T; Niroomand F; Katus HA; Schoels W
Basic Res Cardiol; 2003 Jul; 98(4):259-66. PubMed ID: 12835955
[TBL] [Abstract][Full Text] [Related]
19. Hemodynamics during chronic amiodarone administration in Japanese patients with idiopathic dilated cardiomyopathy and ventricular arrhythmia: a retrospective study.
Suzuki T; Shiga T; Wakaumi M; Matsuda N; Ishizuka N; Kasanuki H
J Cardiol; 2003 Apr; 41(4):169-73. PubMed ID: 12728537
[TBL] [Abstract][Full Text] [Related]
20. [Factors predicting the response to an antiarrhythmic during an electrophysiologic study for ventricular tachycardia].
Brembilla-Perrot B; Terrier de la Chaise A; Skeik L; Cherrier F; Pernot C
Arch Mal Coeur Vaiss; 1987 Sep; 80(10):1497-503. PubMed ID: 3125809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
